Publications by authors named "Thilo Mengling"

Claim this Profile
G
Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor Association.
Angharad Pryce, Meghann Cody, Abeer Madbouly, Eefke van Eerden, Laura L Machin, Thilo Mengling

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy.
Hildegard T Greinix, Arthur Matas, Mickey B C Koh, Lydia Foeken, Nina Worel, Thilo Mengling

Clin Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of serum protein electrophoresis as part of hematopoietic stem cell donor clearance.
Laura Kilinc, Burkhardt Schleipen, Karen Ende, Deborah Buk, Alexander H Schmidt, Thilo Mengling

EJHaem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Findings of Potential Donor Origin following Hematopoietic Cell Transplantation: Recommendations on Donor Disclosure and Genetic Testing from the World Marrow Donor Association.
Angharad Pryce, Eefke Van Eerden, Meghann Cody, Jason Oakes, Anna DeSalvo, Thilo Mengling

Transplant Cell Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the World Marrow Donor Association.
Rachel Pawson, Chloe Anthias, Meghann Cody, Mirjam Fechter, Diane Fournier, Thilo Mengling

Transplant Cell Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues.
Nina Worel, Mahmoud Aljurf, Chloe Anthias, Andreas S Buser, Meghann Cody, Thilo Mengling

Lancet Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New global reporting system for serious (product) events and adverse reactions in hematopoietic stem cell donation and transplantation.
Monique Jöris, Esther Pustjens, Thilo Mengling, Mirjam Fechter, Johanna Wiersum-Osselton

Cell Tissue Bank· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
Thilo Mengling, Gabi Rall, Stefanie N Bernas, Nadia Astreou, Sandra Bochert

Bone Marrow Transplant· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid-19 pandemic.
Alexander H Schmidt, Deborah Buk, Stefanie N Bernas, Thilo Mengling, Elke Neujahr

Am J Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse event reporting for cellular therapy products: Current status and future directions.
Kathy Loper, Michele W Sugrue, Jay S Raval, Joseph Yossi Schwartz, Kevin Land, Thilo Mengling

Transfusion· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenetics in stem cell donor registry work: The DKMS example (Part 2).
Alexander H Schmidt, Jürgen Sauter, Daniel M Baier, Jessica Daiss, Andreas Keller, Thilo Mengling

Int J Immunogenet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).
Alexander H Schmidt, Jürgen Sauter, Daniel M Baier, Jessica Daiss, Andreas Keller, Thilo Mengling

Int J Immunogenet· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Analysis of 37,287 Observation Years after Peripheral Blood Stem Cell Donation.
Alexander H Schmidt, Thilo Mengling, Camila J Hernández-Frederick, Gabi Rall, Julia Pingel

Biol Blood Marrow Transplant· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of hepatitis b virus DNA in the blood of a stem cell donor after granulocyte colony-stimulating factor treatment.
Michael Punzel, Patrick Medd, Hannah Hunter, Richard Cunningham, Bryson Pottinger, Thilo Mengling

Hepatology· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Living Donation of Hematopoietic Stem Cells.
Jeff Szer, Heidi Elmoazzen, Mirjam Fechter, William Hwang, Matti Korhonen, Thilo Mengling

Transplantation· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.
Kristina Hölig, Michael Kramer, Frank Kroschinsky, Martin Bornhäuser, Thilo Mengling

Blood· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation.
Martin Leverkus, Martin R Sprick, Tina Wachter, Thilo Mengling, Bernd Baumann

Mol Cell Biol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis